Ashley Whitechurch, RN

Low grade lymphoma clinical nurse consultant
Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Australia

NA

Poster(s):

• 1162 - Time-limited venetoclax-rituximab is effective for patients with Bruton tyrosine kinase exposed chronic lymphocytic leukaemia, but durable treatment-free remissions are uncommon